Qualitative systematic review of barriers and facilitators to service user-involved antipsychotic prescribing

Research output: Contribution to journalArticlepeer-review

Abstract

Background
Despite policy and practice mandates for service user involvement, people with serious mental illness often feel marginalised in decisions about antipsychotic medication.

Aims
To examine stakeholder perspectives of barriers and facilitators to involving people with serious mental illness in antipsychotic prescribing decisions.

Method
Systematic thematic synthesis.

Results
Synthesis of 29 studies identified the following key influences on involvement: user’s capability, desire and expectation for involvement, organisational context, and the consultation setting and processes.

Conclusions
Optimal user involvement in antipsychotic decisions demands individual and contextual barriers are addressed. There was divergence in perceived barriers to involvement identified by users and prescribers. For example, service users felt lack of time in consultations was a barrier to involvement, something seldom raised by prescribers, who identified organisational barriers. Service users must understand their rights to involvement and the value of their expertise. Organisational initiatives should mandate prescriber responsibility to overcome barriers to involvement.
Original languageEnglish
Pages (from-to)5-14
Number of pages10
JournalBJPsych Open
Volume4
Issue number1
Early online date30 Jan 2018
DOIs
Publication statusPublished - Jan 2018

Fingerprint

Dive into the research topics of 'Qualitative systematic review of barriers and facilitators to service user-involved antipsychotic prescribing'. Together they form a unique fingerprint.

Cite this